NSE & Tata Memorial Centre Partner to Build $42.7M Cancer Care Facility in India
The National Stock Exchange of India (NSE) is investing in the future of cancer treatment through a collaboration with the Tata Memorial Centre (TMC) to construct a new, state-of-the-art multispeciality hospital block and bone-marrow transplant (BMT) centre. This initiative underscores a growing commitment to corporate social responsibility within India’s financial sector and aims to significantly expand access to critical cancer care.
The project, valued at Rs3.8bn ($42.7m), will be located on the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) campus in Navi Mumbai. Construction will be managed by Larsen & Toubro (L&T) utilizing an engineering, procurement, and construction (EPC) model, ensuring efficient and timely completion.
ACTREC, an established institution founded by TMC, will be the beneficiary of this substantial investment. The initiative will be implemented through the NSE Foundation, the exchange’s philanthropic arm. The new facility will encompass a total built-up area of 240,000ft² and is slated to begin operations by July 2027.
A key component of the project is a dedicated 60-bed BMT centre. Projections indicate the centre will serve approximately 130,000 outpatients annually and perform over 600 bone-marrow transplant procedures each year, addressing a critical need for advanced cancer therapies. The facility is designed to provide both specialized and general services, catering to cancer patients with complex comorbidities.
Beyond the BMT centre, the new building will also function as a comprehensive outpatient unit for the entire ACTREC campus. TMC has future plans to develop three additional buildings dedicated to cancer treatment, positioning ACTREC as a leading comprehensive cancer centre. Importantly, the facility will offer life-saving treatments either free of charge or at subsidized rates, ensuring accessibility for a wider patient population.
“NSE is honoured to partner with Tata Memorial Centre in this landmark initiative,” stated Ashishkumar Chauhan, managing director and CEO of NSE. “Our aim is to support the healthcare needs of cancer patients and their families, and to contribute meaningfully to the fight against cancer in India. We believe this project will have a lasting impact on the lives of thousands of patients each year.” Chauhan further emphasized NSE’s broader role as a catalyst for positive change, highlighting its 30-year history of driving economic growth and financial inclusion within India.
This collaboration represents a significant step forward in addressing the growing burden of cancer in India and underscores the power of public-private partnerships in advancing healthcare access and innovation.
